Previous 10 | Next 10 |
Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Corporation") announced the approval of each of the matters set out in the Corporation's Management Information Circular (the " Circular ") dated April 18, 2023 at the 2...
2023-05-25 21:30:23 ET 23andMe Holding Co. (ME) Q4 2023 Results Conference Call May 25, 2023 04:30 PM ET Company Participants Maeve Conneighton - Investor Relations at Argo Partners Anne Wojcicki - Chief Executive Officer & Co-Founder Joe Selsavage - Interim ...
2023-05-25 16:08:36 ET 23andMe press release ( NASDAQ: ME ): Q4 GAAP EPS of -$0.14 beats by $0.04 . Revenue of $92.4M (-8.1% Y/Y) beats by $4M . For further details see: 23andMe GAAP EPS of -$0.14 beats by $0.04, revenue of $92.4M beats by $4M
Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and b...
2023-05-24 17:35:47 ET 23andMe ( NASDAQ: ME ) is scheduled to announce Q4 earnings results on Thursday, May 25th, after market close. The consensus EPS Estimate is -$0.15 and the consensus Revenue Estimate is $88.4M (-12.1% Y/Y). For further details see: 23andMe ...
2023-05-23 09:53:00 ET Most biotechs don't have a diversified business model. They typically develop hardware, diagnostic tests, or drugs, as well as some of the associated platform technologies. But a few competitors, like 23andMe (NASDAQ: ME) and Fulgent Genetics (NASDAQ: FL...
2023-05-19 06:40:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips High-risk penny stocks have long tempted investors with the potential for significant returns. However, it is crucial to acknowledge the inherent risks associated with these speculative...
Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Moneta Gold Inc. (TSX: ME) (OTCQX: MEAUF) (FSE: MOPA) ("Moneta" or the "Company") is pleased to announce that it has closed its previously announced ( see April 19, 2023 press release ) bought deal private placement of 13,868,400 charity f...
66 percent of doctors say genetic testing could lead to better outcomes because patients are more proactive about their health after learning about their DNA health profile 34 percent of doctors said they had personally taken a direct-to-consumer genetic health test SUNNYVALE, Cal...
SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial results for the fiscal year 2023 (FY2023) fourth quarter and full year after the market c...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...